| 2025-12-11 |
详情>>
内部人交易：
Salvadori Daniel Gesua Sive股份减少1536.00股
|
| 2025-10-29 |
详情>>
股本变动：
变动后总股本173887.27万股
变动原因 ▼▲
- 原因：
- 20250630-20250930
股份补偿
发行限制性股票奖励
|
| 2025-10-29 |
详情>>
业绩披露：
2025年三季报(累计)每股收益2.72美元,归母净利润47.48亿美元,同比去年增长13.78%
|
| 2025-10-15 |
财报披露：
美东时间 2025-10-15 盘前发布财报
|
| 2025-07-30 |
详情>>
业绩披露：
2025年中报每股收益1.78美元,归母净利润31.04亿美元,同比去年增长22.83%
|
| 2025-04-30 |
详情>>
业绩披露：
2025年一季报每股收益0.76美元,归母净利润13.25亿美元,同比去年增长8.16%
|
| 2025-03-14 |
股东大会：
将于2025-04-25召开股东大会
会议内容 ▼▲
- 1.Election of the 12 director nominees named in this proxy statement to hold office until the next Annual Meeting or until the next meeting of shareholders at which directors are elected
2.Ratification of the appointment of Ernst & Young LLP as auditors of Abbott for 2025
3.Approval, on an advisory basis, of executive compensation
|
| 2025-03-14 |
股东大会：
将于2025-04-25召开股东大会
会议内容 ▼▲
- 1.Election of the 12 director nominees named in this proxy statement to hold office until the next Annual Meeting or until the next meeting of shareholders at which directors are elected
2.Ratification of the appointment of Ernst & Young LLP as auditors of Abbott for 2025
3.Approval, on an advisory basis, of executive compensation
|
| 2025-02-21 |
详情>>
业绩披露：
2024年年报每股收益7.67美元,归母净利润134.02亿美元,同比去年增长134.18%
|
| 2025-02-21 |
详情>>
业绩披露：
2022年年报每股收益3.94美元,归母净利润69.33亿美元,同比去年增长-1.95%
|
| 2024-10-31 |
详情>>
业绩披露：
2024年三季报(累计)每股收益2.39美元,归母净利润41.73亿美元,同比去年增长1.07%
|
| 2024-07-31 |
详情>>
业绩披露：
2024年中报每股收益1.45美元,归母净利润25.27亿美元,同比去年增长-6.16%
|
| 2024-07-31 |
详情>>
业绩披露：
2023年中报每股收益1.54美元,归母净利润26.93亿美元,同比去年增长-39.69%
|
| 2024-06-03 |
复牌提示：
2024-06-03 10:23:30 停牌，复牌日期 2024-06-03 10:29:17
|
| 2024-05-02 |
详情>>
业绩披露：
2024年一季报每股收益0.70美元,归母净利润12.25亿美元,同比去年增长-7.06%
|
| 2024-03-15 |
股东大会：
将于2024-04-26召开股东大会
会议内容 ▼▲
- 1.Election of the 12 director nominees named in this proxy statement to hold office until the next Annual Meeting or until the next meeting of shareholders at which directors are elected
2.Ratification of the appointment of Ernst & Young LLP as auditors of Abbott for 2024
3.Approval, on an advisory basis, of executive compensation
|
| 2024-03-15 |
股东大会：
将于2024-04-26召开股东大会
会议内容 ▼▲
- 1.Election of the 12 director nominees named in this proxy statement to hold office until the next Annual Meeting or until the next meeting of shareholders at which directors are elected
2.Ratification of the appointment of Ernst & Young LLP as auditors of Abbott for 2024
3.Approval, on an advisory basis, of executive compensation
|
| 2024-02-16 |
详情>>
业绩披露：
2023年年报每股收益3.28美元,归母净利润57.23亿美元,同比去年增长-17.45%
|
| 2023-11-01 |
详情>>
业绩披露：
2023年三季报(累计)每股收益2.36美元,归母净利润41.29亿美元,同比去年增长-30.02%
|
| 2023-03-17 |
股东大会：
将于2023-04-28召开股东大会
会议内容 ▼▲
- 1.Election of the 12 director nominees named in this proxy statement to hold office until the next Annual Meeting or until the next meeting of shareholders at which directors are elected
2.Ratification of the appointment of Ernst & Young LLP as auditors of Abbott for 2023
3.Approval, on an advisory basis, of executive compensation
4.Approval, on an advisory basis, of the frequency of shareholder votes on executive compensation
5.Four shareholder proposals, if properly presented at the meeting
|
| 2023-03-17 |
股东大会：
将于2023-04-28召开股东大会
会议内容 ▼▲
- 1.Election of the 12 director nominees named in this proxy statement to hold office until the next Annual Meeting or until the next meeting of shareholders at which directors are elected
2.Ratification of the appointment of Ernst & Young LLP as auditors of Abbott for 2023
3.Approval, on an advisory basis, of executive compensation
4.Approval, on an advisory basis, of the frequency of shareholder votes on executive compensation
5.Four shareholder proposals, if properly presented at the meeting
|
| 2023-03-17 |
股东大会：
将于2023-04-28召开股东大会
会议内容 ▼▲
- 1.Election of the 12 director nominees named in this proxy statement to hold office until the next Annual Meeting or until the next meeting of shareholders at which directors are elected
2.Ratification of the appointment of Ernst & Young LLP as auditors of Abbott for 2023
3.Approval, on an advisory basis, of executive compensation
4.Approval, on an advisory basis, of the frequency of shareholder votes on executive compensation
5.Four shareholder proposals, if properly presented at the meeting
|
| 2022-03-18 |
股东大会：
将于2022-04-29召开股东大会
会议内容 ▼▲
- 1.Election of the 12 director nominees named in this proxy statement to hold office until the next Annual Meeting or until the next meeting of shareholders at which directors are elected
2.Ratification of the appointment of Ernst & Young LLP as auditors of Abbott for 2022
3.Approval, on an advisory basis, of executive compensation
4.Five shareholder proposals, if properly presented at the meeting
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-12 |
股东大会：
将于2021-04-23召开股东大会
会议内容 ▼▲
- 1.Election of the 13 director nominees named in this proxy statement to
hold office until the next Annual Meeting or until the next meeting of
shareholders at which directors are elected
2.Ratification of the appointment of Ernst & Young LLP as auditors of
Abbott for 2021
3.Approval, on an advisory basis, of executive compensation
4.Approval and adoption of amendments to the Articles of Incorporation
to eliminate statutory supermajority voting standards for:
4.1.amendments to the Articles of Incorporation,
4.2.approval of certain extraordinary transactions
5.Three shareholder proposals, if properly presented at the meeting
|
| 2020-03-13 |
股东大会：
将于2020-04-24召开股东大会
会议内容 ▼▲
- 1.To elect the 14 directors named in this proxy statement to hold office until the next Annual Meeting or until the next meeting of shareholders at which directors are elected (Item 1 on the proxy card)
2.To ratify the appointment of Ernst & Young LLP as auditors of Abbott for 2020 (Item 2 on the proxy card)
3.To vote on an advisory vote on the approval of executive compensation (Item 3 on the proxy card)
4.To transact such other business as may properly come before the meeting, including consideration of shareholder proposals, if presented at the meeting (Items 4, 5, 6, and 7 on the proxy card).
|
| 2020-02-21 |
除权日：
美东时间 2020-04-14 每股派息0.36美元
|
| 2019-12-13 |
除权日：
美东时间 2020-01-14 每股派息0.36美元
|
| 2019-09-12 |
除权日：
美东时间 2019-10-11 每股派息0.32美元
|
| 2019-06-14 |
除权日：
美东时间 2019-07-12 每股派息0.32美元
|
| 2019-03-15 |
股东大会：
将于2019-04-26召开股东大会
会议内容 ▼▲
- 1.To elect 13 directors to hold office until the next Annual Meeting or until their successors are elected (Item 1 on the proxy card),
2.To ratify the appointment of Ernst & Young LLP as auditors of Abbott for 2019 (Item 2 on the proxy card),
3.To vote on an advisory vote on the approval of executive compensation (Item 3 on the proxy card),
4.To transact such other business as may properly come before the meeting, including consideration of a shareholder proposal, if presented at the meeting (Item 4 on the proxy card).
|
| 2019-02-22 |
除权日：
美东时间 2019-04-12 每股派息0.32美元
|
| 2018-12-14 |
除权日：
美东时间 2019-01-14 每股派息0.32美元
|
| 2018-09-13 |
除权日：
美东时间 2018-10-12 每股派息0.28美元
|
| 2018-06-08 |
除权日：
美东时间 2018-07-12 每股派息0.28美元
|
| 2018-03-16 |
股东大会：
将于2018-04-27召开股东大会
会议内容 ▼▲
- 1.To elect 12 directors to hold office until the next Annual Meeting or until their successors are elected (Item 1 on the proxy card)
2.To ratify the appointment of Ernst & Young LLP as auditors of Abbott for 2018 (Item 2 on the proxy card)
3.To vote on an advisory vote on the approval of executive compensation (Item 3 on the proxy card)
4.To transact such other business as may properly come before the meeting, including consideration of a shareholder proposal, if presented at the meeting (Item 4 on the proxy card).
|
| 2018-02-16 |
除权日：
美东时间 2018-04-12 每股派息0.28美元
|
| 2017-12-15 |
除权日：
美东时间 2018-01-11 每股派息0.28美元
|
| 2017-09-14 |
除权日：
美东时间 2017-10-12 每股派息0.27美元
|
| 2017-06-09 |
除权日：
美东时间 2017-07-12 每股派息0.27美元
|
| 2017-03-17 |
股东大会：
将于2017-04-28召开股东大会
会议内容 ▼▲
- 1.To elect 11 directors to hold office until the next Annual Meeting or until their successors are elected (Item 1 on the proxy card),
2.To ratify the appointment of Ernst & Young LLP as auditors of Abbott for 2017 (Item 2 on the proxy card),
3.To vote on an advisory vote on the approval of executive compensation (Item 3 on proxy card),
4.To vote on an advisory vote on the approval of the frequency of shareholder votes on executive compensation (Item 4 on proxy card),
5.To approve the adoption of the Abbott Laboratories 2017 Incentive Stock Program (Item 5 on the proxy card),
6.To approve the adoption of the Abbott Laboratories 2017 Employee Stock Purchase Plan for Non-U.S. Employees (Item 6 on the proxy card),
7.To transact such other business as may properly come before the meeting, including consideration of a shareholder proposal, if presented at the meeting (Item 7 on the proxy card).
|
| 2017-02-17 |
除权日：
美东时间 2017-04-11 每股派息0.27美元
|
| 2016-12-09 |
除权日：
美东时间 2017-01-11 每股派息0.27美元
|
| 2016-09-15 |
除权日：
美东时间 2016-10-12 每股派息0.26美元
|
| 2016-06-10 |
除权日：
美东时间 2016-07-13 每股派息0.26美元
|
| 2016-03-18 |
股东大会：
将于2016-04-29召开股东大会
会议内容 ▼▲
- 1.To elect 11 directors to hold office until the next Annual Meeting or until their successors are elected (Item 1 on the proxy card),
2.To ratify the appointment of Ernst & Young LLP as auditors of Abbott for 2016 (Item 2 on the proxy card),
3.To vote on an advisory vote on the approval of executive compensation (Item 3 on proxy card).
4.To transact such other business as may properly come before the meeting.
|
| 2016-02-19 |
除权日：
美东时间 2016-04-13 每股派息0.26美元
|
| 2015-12-11 |
除权日：
美东时间 2016-01-13 每股派息0.26美元
|
| 2015-09-17 |
除权日：
美东时间 2015-10-13 每股派息0.24美元
|
| 2015-06-12 |
除权日：
美东时间 2015-07-13 每股派息0.24美元
|
| 2015-02-20 |
除权日：
美东时间 2015-04-13 每股派息0.24美元
|
| 2014-12-12 |
除权日：
美东时间 2015-01-13 每股派息0.24美元
|
| 2014-09-11 |
除权日：
美东时间 2014-10-10 每股派息0.22美元
|
| 2014-06-13 |
除权日：
美东时间 2014-07-11 每股派息0.22美元
|
| 2014-02-21 |
除权日：
美东时间 2014-04-11 每股派息0.22美元
|
| 2013-10-16 |
除权日：
美东时间 2014-01-13 每股派息0.22美元
|
| 2013-09-12 |
除权日：
美东时间 2013-10-10 每股派息0.14美元
|
| 2013-06-14 |
除权日：
美东时间 2013-07-11 每股派息0.14美元
|
| 2013-02-15 |
除权日：
美东时间 2013-04-11 每股派息0.14美元
|
| 2012-12-14 |
除权日：
美东时间 2013-01-11 每股派息0.14美元
|
| 2012-09-13 |
除权日：
美东时间 2012-10-11 每股派息0.51美元
|
| 2012-06-08 |
除权日：
美东时间 2012-07-11 每股派息0.51美元
|
| 2012-02-17 |
除权日：
美东时间 2012-04-11 每股派息0.51美元
|
| 2011-12-09 |
除权日：
美东时间 2012-01-11 每股派息0.48美元
|
| 2011-09-15 |
除权日：
美东时间 2011-10-12 每股派息0.48美元
|
| 2011-06-10 |
除权日：
美东时间 2011-07-13 每股派息0.48美元
|
| 2011-02-18 |
除权日：
美东时间 2011-04-12 每股派息0.48美元
|
| 2010-12-10 |
除权日：
美东时间 2011-01-12 每股派息0.44美元
|
| 2010-09-16 |
除权日：
美东时间 2010-10-13 每股派息0.44美元
|
| 2010-06-11 |
除权日：
美东时间 2010-07-13 每股派息0.44美元
|